Lataa...
Targeting survival pathways in chronic myeloid leukaemia stem cells
Chronic myeloid leukaemia (CML) is a clonal myeloproliferative disorder characterized by the presence of a fusion oncogene BCR-ABL, which encodes a protein with constitutive TK activity. The implementation of tyrosine kinase inhibitors (TKIs) marked a major advance in CML therapy; however, there are...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Blackwell Publishing Ltd
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3753830/ https://ncbi.nlm.nih.gov/pubmed/23517124 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.12183 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|